Abstract 248: Dynamic multi-OMICS analysis of glioblastoma cells reveals context of vulnerability to neddylation inhibition by pevonedistat
Shayesteh R. Ferdosi(Translational Genomics Research Institute), Harshil Dhruv(Arysta LifeScience (France)), Ritin Sharma(Translational Genomics Research Institute), Krystine Garcia‐Mansfield(Translational Genomics Research Institute), Patrick Pirrotte(Translational Genomics Research Institute), Brett Taylor(Translational Genomics Research Institute), Rita Bybee(Translational Genomics Research Institute), Sen Peng(Translational Genomics Research Institute), Victoria David‐Dirgo(Translational Genomics Research Institute), Michael Berens(Translational Genomics Research Institute), Nanyun Tang(Translational Genomics Research Institute)
Cited by 0
Related Papers
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
|Nature Communications|2019|199
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
|Cell Reports|2020|108
Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma
|Cancer Research|2019|99
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
|Nature Communications|2018|79